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Cognitive impairment in COPD: an often overlooked co-morbidity. 
1. Introduction 
Chronic Obstructive Pulmonary Disease (COPD) is a disease of multiple co-morbidities, such as lung 
cancer, coronary artery disease and osteoporosis  [1]. Co-morbid neurocognitive damage and 
dysfunction is frequently overlooked despite a growing body of well conducted cross sectional and 
longitudinal studies pointing to a frequent and important association. A diagnosis of mild cognitive 
impairment (MCI); when deficits develop in cognitive domains,  is important since it is known to 
worsen outcomes and increase healthcare burden in COPD [2]. MCI has 5-10% annual conversion 
rate to dementia, but crucially is considered a potentially reversible state [3]. It is therefore an 
urgent public health priority to clarify risk factors for MCI. Although epidemiological research 
suggests that COPD increases the risk of cognitive impairment, establishing causality is challenging. 
Various pathological mechanisms are hypothesised including hypoxia and structural brain changes. 
In this expert opinion we will discuss evidence for the association of COPD and cognitive impairment, 
possible underlying mechanisms, the impact on morbidity and mortality, and suggest how future 
research could help us understand and manage this common co-morbidity. 
 
2. Epidemiological evidence linking COPD and cognitive impairment 
 
Most observational epidemiological research suggests COPD is associated with an increased risk of 
cognitive impairment, although estimates vary. A literature review including 17 studies estimated  a 
prevalence of cognitive dysfunction ranging from 10-61% in COPD [3]. A systematic review found 8 
of 12 studies reviewed reported increasing cognitive dysfunction with worsening COPD severity [4]. 
Longitudinal work has demonstrated that COPD can influence the risk of developing MCI. A large 
retrospective observational cohort study showed midlife obstructive lung disease was associated 
with increased risk of developing of Alzheimer’s or MCI Odd Ratio (OR) 1.33 (95% CI, 1.07-1.64) [5].  
The pattern of cognitive impairment has been studied, with evidence of a global impairment in some 
groups, whilst others show a COPD specific pattern of deficits in attention, memory, learning and 
motor functions[3]. As the extent and pattern of cognitive deficits vary, multiple psychometric tests 
are required for full evaluation in research and clinical practice [6].  
 Methodological errors may be contributing to mixed results. Observational studies often lack a 
matched smoking control group, despite smoking being an important risk factor for cognitive 
impairment. Case control studies are often limited by small numbers of participants weakening 
power. Cohort studies often rely on health care records for diagnoses of COPD and cognitive 
impairment, which may be inaccurate. Meta-analyses are not always possible due to differing 
definitions and tests of cognitive impairment, heterogenous sample populations, and poor outcome 
definitions (MCI and dementia are often merged).  
3. Hypothesis for mechanism linking COPD and cognitive impairment 
 
The exact aetiological link between COPD and cognitive impairment remains unknown. Proposed 
casual mechanisms include hypoxia mediated neuronal damage or reduction in neurotransmitters 
that require oxygen-dependent enzymes for synthesis. A meta-analysis of nine studies found a 
negative correlation between PaO2 and cognitive function with a  pooled r = 0.405, 95% CI 0.31-0.55, 
but with sizeable heterogeneity, so the impact of hypoxia mechanism remains uncertain [7]. Hypoxia 
cannot be the sole mediator as cognitive deficits have been found in both hypoxic and non-
hypoxaemic patients.  Acute oxygen therapy doesn’t impact cognitive function [8],  and whilst long 
term oxygen has been shown to improve cognition, it is dependent on which cognitive test is being 
used [9]. Therefore, although hypoxia may explain some cognitive deficit, other factors are also 
important. The relationship with carbon dioxide is even less clear with some studies showing a 
relationship with executive function, attention and verbal memory with others showing no 
relationship [10].  
Vascular brain disease is a common comorbidity in COPD, as identified in up to 50% of inpatients [3]. 
Several plausible mechanisms for vascular disease in COPD have been suggested including systemic 
inflammation, oxidative and physiological stress [11]. The pattern of vascular brain disease seen in 
COPD appears to differ from that of ischaemic cerebrovascular disease and vascular dementia. 
Microvascular disease is increased in COPD patients compared to smoking controls, as demonstrated 
by significant arteriole and venous dilation in retinal images. These changes are associated with lung 
function independent of standard cardiovascular risk factors [12]. Neuroimaging has revealed grey 
matter atrophy in COPD patients that cannot be explained by cardiovascular risk and smoking alone. 
Cerebral white matter lesions (a marker of cerebrovascular pathology) are seen, but may lead to 
anxiety and depression rather than significant cognitive impairment [13]. Functional and diffusion 
MRI has shown widespread disturbance in activity of grey matter, and reduced white matter 
integrity throughout the brain [14]. Brain networks in those with COPD show more evidence of 
damage than in controls, but this does not appear sufficient to reduce the networks’ efficiency, and 
direct relationships with cognitive measures have not been found [15].  
It is important to consider smoking since it increases the risk of both COPD and vascular brain 
disease. For example, smokers MRI’s reveal increased periventricular white matter hyperintensities. 
The effect may be dose dependent with greater pack/years associated with greater brain atrophy, 
larger sulcal and ventricle volumes [16]. Smoking does not explain all the risk of vascular brain 
disease and cognitive impairment. Even adjustment for smoking, lung function remains associated 
with white matter brain lesions, with a ‘dose response’ like relationship between severity of lung 
function deficit and risk of cognitive impairment [17,18]. 
During acute exacerbations patients with COPD have greater cognitive impairment than similar 
patients with acute heart failure [19]. This acute cognitive deterioration is seen to improve over six 
weeks in most, but not in all patients [20]. Whether exacerbations change cognition in the long term 
is unclear.  
Physical activity may positively impact cognition in patients with COPD. Proposed mechanisms 
include decreasing oxidative stress, reducing systemic inflammation and improving microvascular 
circulation [21].  Reduced mobility can contribute to social isolation, anxiety and depression 
potentially contributing to progressive cognitive impairment. Exercise programs to improve 
cognition have been studied, however a meta-analysis of trials is not possible due to heterogeneity 
of studies, typifying research issues in this field [22]. It remains uncertain if pulmonary rehabilitation 
and exercise classes will improve cognition. 
4. Impact of cognitive impairment in COPD 
 
Whilst efforts to fully understand the causal and aetiological relationship between COPD and 
cognition is ongoing, the impact on morbidity is clear. Impairment in memory, cognitive flexibility 
and visual processing may have direct impact on COPD patients’ ability to self-manage their disease 
[6]. Studies have shown greater disability, risk of exacerbation, and poorer medication compliance in 
those with cognitive impairment [2,10,23]. The effect of cognitive impairment on mortality in COPD 
is less certain. Cognitive dysfunction is associated with increased mortality in acute hospital 
admissions even in those without COPD, but its effect specifically in the COPD population has not 
been well studied and available results are mixed [10]. A large prospective study in COPD found no 
link between mortality and Mini Mental State Examination (MMSE), whilst another study found 
drawing impairment was a risk factor for mortality in those with severe COPD [10,24].  
 
5. 5 Year View 
 
Despite decades of research, our understanding of cognitive impairment in COPD remains 
incomplete. Most studies are in small populations, often repeating previous study methodologies 
but with different cognitive tests. Other studies examine narrow putative pathological processes, 
even though we are yet to ascertain if COPD directly causes increased risk of cognitive impairment. 
Given the significant shared risk factors, even after adjustment for confounders, traditional 
observational studies will not determine causality. Novel epidemiological techniques to infer 
causality such as Mendelian Randomization offer the opportunity to explore this important gap in 
our knowledge.  
Our understanding of COPD pathogenesis is evolving, which in turn should change the way that we 
think about the relationship between COPD and its co-morbidities. It is becoming clear that COPD 
and lung function decline is not simply due to smoking, but early life factors significantly affect lung 
development and lung function trajectories. Available data points to a link between impaired lung 
function and cardiovascular co-morbidity as early as the third decade [25]. More work is needed to 
see when, and to what extent, cognitive deficits are associated with these trajectories.  
Large consortiums and birth cohorts will provide bigger, longitudinal samples to facilitate more 




Whilst it remains unclear if COPD causes cognitive impairment, and what the underlying mechanisms 
could be, there is an association between COPD and cognition which is harmful to an already 
vulnerable population. Too often observational analysis of prevalence and underlying mechanism 
are being repeated, with varying cognitive tests in small heterogenous populations preventing meta-
analysis and definitive conclusions. We welcome research designed to evaluate causality of the 
relationship and suggest use of Mendelian Randomization. However, if the association is not causal 
and the result of shared environmental, genetic or behavioural processes it is important to not 
overlook the impact of impaired cognition on people living with COPD. Research to discover 
pharmacological and non-pharmacological interventions to manage cognitive impairment in both 
acute and stable COPD patients should also be prioritised. 
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